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Neisseria gonorrhoeae ordinarily requires both HpuA and HpuB to use hemoglobin (Hb) as a source of iron
for growth. Deletion of HpuA resulted in reduced Hb binding and failure of growth on Hb. We identified rare
Hb-utilizing colonies (Hb) from an hpuA deletion mutant of FA1090, which fell into two phenotypic classes.
One class of the Hb revertants required expression of both TonB and HpuB for growth on Hb, while the other
class required neither TonB nor HpuB. All TonB/HpuB-dependent mutants had single amino acid alterations
in HpuB, which occurred in clusters, particularly near the C terminus. The point mutations in HpuB did not
restore normal Hb binding. Human serum albumin inhibited Hb-dependent growth of HpuB point mutants
lacking HpuA but did not inhibit growth when expression of HpuA was restored. Thus, HpuB point mutants
internalized heme in the absence of HpuA despite reduced binding of Hb. HpuA facilitated Hb binding and was
important in allowing use of heme from Hb for growth.
Mammalian hosts use iron-binding proteins and iron-se-
questering compounds to maintain free iron at a level that is
too low for the growth of invading pathogens. Iron bound to
hemoglobin (Hb) is a significant constituent of the total iron in
the human body, but it is not readily available to pathogens
because of its compartmentalization in erythrocytes. Patho-
genic neisseriae are able to use Hb, haptoglobin-hemoglobin
(Hp-Hb), and heme as a source of iron for growth (12). Neis-
seriae have two distinct Hb receptors, the bipartite outer mem-
brane Hb receptor, HpuAB, which acquires iron from Hb and
Hb-Hp, and HmbR, which utilizes iron from Hb (7, 8, 15, 16,
23). Some meningococci express either HpuAB or HmbR,
while others express both (23). HpuAB is most likely the only
Hb receptor of gonococci, since all strains tested are capable of
expressing HpuAB through phase variation (7, 8), but there is
a premature stop codon in hmbR of gonococci (23).
Most laboratory and clinical Neisseria gonorrhoeae isolates
do not express HpuAB and are unable to use Hb as the sole
source of iron for growth (Hb). A small population (ca. 0.1%)
of every tested Hb N. gonorrhoeae isolate is able to express
HpuAB and utilize Hb under iron-stressed conditions (Hb).
Expression of HpuAB phase varies due to translational frame-
shifting resulting from slipped-strand mispairing of a poly(G)
tract within the coding sequence of hpuA (8). The receptor
consists of a lipoprotein, HpuA, and a transmembrane protein,
HpuB. Growth on Hb is TonB dependent and requires both
HpuA and HpuB (3, 8). In contrast, in the related gonococcal
TonB-dependent receptors for transferrin and lactoferrin, the
lipoproteins TbpB and LbpB are not absolutely required for
growth, although they play a role in facilitating ligand binding
(2, 4). HpuA can be isolated with HpuB by binding to Hb-
agarose, but not in the absence of HpuB, indicating physical
contact between these two proteins (8).
Pathogenic neisseriae can also use free heme as an iron
source for growth. Growth with heme requires neither HpuAB
nor TonB (3, 7, 24, 26). The existence of a heme receptor has
been suggested (13, 14), but a heme receptor has never been
clearly identified in either meningococci or gonococci. Path-
ways for entry and transport of free heme are not well under-
stood. Construction of hemA mutants that cannot synthesize
heme proved that meningococci and gonococci can utilize Hb
as a heme source and that uptake of heme from either Hb or
Hb-Hp requires HpuAB (17, 26). Heme-dependent growth
does not require FbpA (26); FbpA is required to shuttle iron
from transferrin and lactoferrin through the periplasmic space
(1, 6).
As part of an effort to examine the role of HpuA and HpuB
in the function of the gonococcal Hb receptor, we constructed
a nonpolar hpuA deletion (hpuA) mutant that could express
HpuB under the control of the hpuA promoter. The HpuA
HpuB mutant was unable to grow on Hb. We were able to
identify two different classes of Hb revertants from this
HpuA mutant. The first class had point mutations in hpuB,
and their growth on Hb depended on the expression of both
HpuB and TonB. The second class consisted of mutants that
grew on Hb in a TonB- and HpuB-independent manner. Char-
acteristics of the HpuA-independent/HpuB-dependent Hb uti-
lization are reported here.
MATERIALS AND METHODS
Bacterial strains and growth conditions. The parent strain used in this study
was FA1090. Plasmids and gonococcal strains constructed and/or used in this
study are listed in Table 1. The growth conditions for FA1090, various mutants,
and Escherichia coli strains were as described (26). Hb isolates were grown on
Bacto GC medium base (Difco, Becton Dickinson, Sparks, Md.) plates (GCB
plates) containing Kellog’s supplement I, ferric nitrate at 12 M. The off to on
(Hb to Hb) phase variation frequency of FA1090 was about 103 (7). The
Hb isolates were grown on modified GCB plates (Hb/Des plates) containing
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human Hb at a concentration of 2 M and deferoxamine mesylate (Desferal) at
100 M instead of ferric nitrate.
Antibiotics were used at the following concentrations: for E coli strains, am-
picillin at 100 g/ml, erythromycin at 100 g/ml, chloramphenicol at 30 g/ml,
and kanamycin at 30 g/ml; for gonococcal strains, erythromycin at 1 g/ml,
chloramphenicol at 1 g/ml, and spectinomycin at 100 g/ml. A stock solution of
heme was prepared by dissolving 10 mg of heme (Sigma; bovine hemin chloride)
in 1 ml of 0.1 N NaOH. To prepare a stock solution of Hb, 100 mg of Hb (Sigma;
human hemoglobin) was dissolved in 10 ml of 10 mM HEPES (pH 7.4), rocked
overnight in a 4°C cold room, and sterile filtered through 0.45-m-pore-size
Acrodisc (Pall Gelman Laboratory, Ann Arbor, Mich.).
Reagents, isotope, oligonucleotide, and DNA sequencing. All chemicals were
purchased from Sigma, St. Louis, Mo., unless otherwise indicated. Iodine-125
was purchased from Amersham Pharmacia Biotech, United Kingdom. Oligonu-
cleotides were synthesized at the Lineberger Comprehensive Cancer Center
DNA Synthesis Facility of the University of North Carolina-Chapel Hill. Se-
quencing was carried out at the Automated DNA Sequencing Facility of the
University of North Carolina-Chapel Hill with an Applied Biosystems model 373
DNA sequencer by use of the Taq Dye Terminator cycle sequencing kit (Applied
Biosystems, Perkin-Elmer, Foster City, Calif.).
Construction of hpuA deletion mutants which express HpuB under the control
of the hpuA promoter. PCR-amplified DNA of the hpuA promoter region of the
FA1090 Hb variant was inserted into the vector pCR2.1-TOPO (Invitrogen,
Carlsbad, Calif.) and cloned in E. coli DH5MCR to generate pUNCH277. The
upstream PCR primer uphpuA (5-TATCGGCCCGTCGCGCAAAACGTGTT
CC-3) started at 567 bp from the beginning of the hpuA coding sequence and
carried an added EagI site at the 5end. The downstream primer hpuApro
(5-ACGCATATGATGTATTAATAATAGTTTTGATTATC-3) started at 17
bp from the ATG site and carried an added NdeI site at the 3 end.
Another plasmid, pUNCH278, carrying PCR-amplified DNA of FA1090
TABLE 1. Plasmids and gonococcal strains constructed and/or used in this study
Plamid or strain Relevant characteristics Source or reference
Plasmids
PCR2.1-TOPO Vector for inserting PCR product Invitrogen Corp.
pHP45 Source for  (Spr Smr) cassette 20
pNC40 Source for cat (Cmr) cassette 25
pSM85kE 850-bp ApoI fragment of meningococcal hpu::mTn3erm 15
pIRS756 hmbR from IR1113 (MS11 gene) 23
pIRS756-CAT hmbR::cat This study
pIRS756- hmbR:: This study
pUNCH173 tonB:: 3
pUNCH1306 hemA:: 26
pUNCH272 pCR2.1-TOPO with coding sequence of mature HpuB This study
pUNCH277 pCR2.1-TOPO with hpuA promoter region PCR insert This study
pUNCH278 pCR2.1-TOPO with hpuB PCR insert This study
pUNCH279 pUNCH278 with cat cassette from pNC40 inserted in
hpuB
This study
pUNCH280 Ligated hpuA promoter with hpuB::CAT in pCR2.1-TOPO This study
Strains
FA1090 Wild-type parent strain 11
FA1090 Hb HpuAB phase on variant of FA1090 7
FA6929 hpuB::mTn3erm mutant of FA1090 Hb variant, Emr Hb 7
FA6982 hpuA:: mutant of FA1090 Hb Spr Hb This study
FA6983 hpuA::aphA-3 mutant of FA1090 Hb, Kmr Hb This study
FA7167 hpuA hpuB::cat Cmr Hb This study
FA7168 Cms Hb revertant of FA7167 This study
FA7169 hpuA hpuB derivative of FA7167, Cms Hb This study
FA7170 Cms Hb revertant of FA7169, hpuB*650 (G217D) This study
FA7184 hmbR:: mutant of FA7168, Spr Hb This study
FA7185 hmbR::cat mutant of FA7169, Cmr Hb This study
FA7185H1 Cmr Hb revertant of FA7185, hpuB*2369 (G790D) This study
FA7185H2 Cmr Hb revertant of FA7185, hpuB*2369 (G790D) This study
FA7185H11 Cmr Hb revertant of FA7185, hpuB*2199 (S733R) This study
FA7185H12 Cmr Hb revertant of FA7185, hpuB*1526 (G509V) This study
FA7185H13 Cmr Hb revertant of FA7185, hpuB*2378 (R793L) This study
FA7185H14 Cmr Hb revertant of FA7185, hpuB*770 (A257D) This study
FA7186 hmbR:: mutant of FA7169, Spr Hb This study
FA7186H1 Spr Hb revertant of FA7186 This study
FA7186H2 Spr Hb revertant of FA7186, hpuB*2369 (G790D) This study
FA7186H16 Spr Hb revertant of FA7186, hpuB*2369 (G790D) This study
FA7186H17 Spr Hb revertant of FA7186, hpuB*2181 (W727C) This study
FA7187 hmbR::cat mutant of FA7170, Spr Hb This study
FA7188 hmbR:: mutant of FA7170, Spr Hb This study
FA7199 tonB:: mutant of FA7168, Spr Hb This study
FA7200 tonB:: mutant of FA7170, Spr Hb This study
FA7229 tonB:: mutant of FA7185H1, Spr Hb This study
FA7242 FA6929 with hpuB* from FA7170, Ems Hb This study
FA7243 FA6929 with hpuB* from FA7185H14, Ems Hb This study
FA7244 hemA:: mutant of FA7170, Spr Hb This study
FA7245 hemA:: mutant of FA7185H14, Spr Hb This study
FA7246 hpuB::cat mutant of FA7186H2, Cmr Hb This study
FA7247 hpuB::cat mutant of FA7186H17, Cmr Hb This study
FA7288 hemA:: mutant of FA7169, Spr Hb This study
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hpuB, including its own ribosome-binding site, was constructed in the same way.
The upstream primer hpuBrbs (5-ATACATATGGCAAAGGTTTCTTATGC
CCATTCC-3) started at 13 bp from the ATG site, and the downstream primer
hpu.61 (5-TATCGGCCGGGGGCGGCGGTGCGACC-3) started at 80 bp af-
ter the TAA terminator site. They carried added NdeI and EagI sites at the 5 and
3 ends, respectively. A 1-kb cassette carrying the gene for chloramphenicol
acetyltransferase (cat cassette) was inserted at the ClaI site of pUNCH278, 1,059
bp downstream from the ATG, to make pUNCH279. The hpuB::cat fragment of
pUNCH279 was isolated by NdeI-AvaI double digestion and inserted into the
NdeI-AvaI double-digested pUNCH277 to produce pUNCH280.
The DNA fragment from pUNCH280 carrying the hpuA promoter followed by
hpuB::cat was isolated with HindIII and transformed into the FA1090 Hb
variant to make FA7167. One of the HindIII sites was at the vector polylinker
region, and the other was 687 bp before the TAA terminator site. FA7167 was
Hb and chloramphenicol resistant (Cmr). Transformation of FA7167 with
pUNCH272 carrying the coding sequence for mature HpuB resulted in FA7169
(Fig. 1). The primer pair used to amplify this section of hpuB was hpu.51
(5-TATACATATGGCAGACCCCGCGCCGCAGTC-3) and hpu.61. FA7169
was chloramphenicol sensitive (Cms) and Hb, as expected. During the con-
struction, we observed unexpected rare Cms Hb colonies on the Hb/Des plates.
Two of the colonies were isolated, characterized, and named FA7168 and
FA7170.
Detection of HpuA and HpuB. Expression of HpuA and HpuB was examined
by Western blots and dot blots. Strains were grown in iron-sufficient and iron-
limited media as described previously (8). Crude lysates prepared from iron-
stressed and iron-replete cell suspensions were separated by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) followed by electro-
phoretic transfer to nitrocellulose. Polyclonal antibodies raised in rabbits against
either the N terminus of HpuB or the C terminus of HpuA were used for
detection of HpuB and HpuA in Western blots (8). Whole-cell dot blots were
prepared from wells loaded with 100 l of cell suspensions at an optical density
at 600 nm (OD600) of 0.2. Dot blots were dried, blocked with 5% dry milk, and
probed with rabbit antisera raised against either recombinant HpuB or HpuAB
affinity purified on an Hb-agarose column.
Mutagenesis of hmbR, tonB, and hemA. The hmbR gene of FA7168, FA7169,
and FA7170 was mutagenized with either the  or the cat cassette. The con-
structions started with pIRS756 (a gift from I. Stojiljkovic of Emory University)
containing the hmbR gene of gonococcal strain MS11. The cat cassette was
inserted at the PstI site and the  cassette was inserted at the blunted AgeI site
of hmbR. The pCR2.1-TOPO-cloned hmbR::cat and hmbR:: fragments were
isolated and used in transformations to derive Cmr and spectinomycin-resistant
(Spr) transformants, respectively. The TonB dependence of Hb revertants was
tested by insertional inactivation of tonB with the  cassette. This procedure
used the tonB:: plasmid pUNCH173 (3) to transform various hpuA mutants
and selected for Spr. The ability of hpuA mutants to utilize Hb as a heme source
was tested by the construction of hemA mutants with the hemA:: plasmid
pUNCH1306 described by Turner et al. (26).
Hb revertants of hpuA deletion mutants. After initial recognition of FA7168
and FA7170, more Hb mutants were selected from the hmbR mutants of
FA7169, FA7185 (hmbR::cat), and FA7186 (hmbR::) by plating on Hb/Des
plates.
Primers for PCR and DNA sequencing. The design of primers was based on
analysis of contiguities released from the University of Oklahoma Gonococcal
Genome Sequencing Project (21). The sequence of hpuB in Hb mutants of
hpuA parents was examined by sequencing PCR-amplified genomic DNA.
Amplification of hpuB used the primer pair hpuBrbs and hpu.61. The sequencing
used eight primers as needed to read through hpuB: hpu.05 (5-TCCCTTCAA
ACCCGTATTGGCT-3), hpu.09 (5-ATTCAGCAGCATTACCGCCG-3),
hpu.07 (5-GCGGCGCAATACGGCTTAG-3), hpu.11 (5-AGATACGCCCC
GCTTTCAGA-3), hpu.10 (5-ATTTCGACATCGCCCTCGGT-3), hpu.08
(5-CCGCCCAAGTGAAACACATTGT-3), hpu.12 (5-ATGTAGCTGACGT
TGAGGCC-3), and hpu.61.
Dependence of Hb-supported growth on HpuB expression. DNA sequencing
showed that one class of Hb mutants had point mutations in hpuB, which were
designated hpuB*. Insertional inactivation of HpuB was carried out in hpuA
hpuB* mutants FA7186H2 and FA7186H17 to confirm that point mutation in
HpuB was the factor responsible for their Hb phenotype. PCR products pre-
pared from the region flanking the cat insert in the hpuB of FA7167 were used
as the transforming DNA. The upstream primer, hpu.09, and the downstream
primer, hpu.08, covered an hpuB fragment of 795 bp, not counting the insertion.
The transformants were selected for Cmr and scored for inability to grow on
Hb/Des plates.
Moving HpuB point mutants into an HpuA background. The role of HpuA
in gonococcal Hb utilization was examined by comparing the growth of hpuA
hpuB* and hpuA hpuB* mutants. PCR-amplified hpuB was prepared from two
hpuB* mutants, FA7170 and FA7185H14, and moved into FA6929, which is
hpuA hpuB::mTn3erm. Transformants were selected for growth on Hb/Des
plates and scored for sensitivity to erythromycin (Ems). The hpuB of selected
Hb Ems transformants was PCR amplified and sequenced to verify that the
hpuB point mutations were preserved and the mTn3erm cassette of FA6929 had
been replaced.
Plate assays for Hb and heme utilization and detergent and antibiotic sensi-
tivity. The phenotype of various mutants was assessed by spreading 100 l of a
1:100 dilution of cell suspensions at an OD600 of 0.4 onto GCB/Des or GCB
plates. To test for growth, wells (0.6 cm in diameter) were cut into the agar and
filled with 60 l of heme at 0.1 mg/ml or Hb at 10 mg/ml (26). To test for
antimicrobial sensitivity, filter paper disks (0.6 cm in diameter) were placed on
the GCB plate surface and 5 l of test solution was dropped at the center of the
disks. Chloramphenicol was used at 0.3 g/l, rifampin was used at 0.1 g/l,
and Triton X-100 was used at a 1:100 dilution.
Liquid culture assays. Liquid cultures were started from gonococci grown
overnight on Chelex-treated defined medium (CDM) plates containing 5 M
ferric nitrate (12). Ten milliliters of liquid CDM was inoculated to approximately
20 Klett units and incubated with shaking at 37°C in a 5% CO2 atmosphere for
2 h. Once the starting culture reached about 30 Klett units, fresh CDM contain-
ing the iron sources of interest was inoculated to a starting Klett unit of about 5
for Hb cultures and about 10 for heme cultures. Hb was used at a final concen-
tration of 1 M, while heme was tested at concentrations varying between 0.05
and 5 M. Desferal was added to all Hb and heme media to 100 M. For
iron-stressed growth, only Desferal was added to the liquid culture. Human
serum albumin (HSA) was added as indicated to a final concentration of 16 M.
Hb-binding assays. Two kinds of Hb-binding assays were carried out using
either biotinylated human Hb or iodinated anti-Hb antibody. The biotinylated
Hb-whole-cell dot blot assay has been described previously (7). The radioimmu-
noassay used iodinated goat anti-human Hb antibodies (affinity purified; Bethyl
Laboratories, Montgomery, Tex.) instead of Hb because of the difficulty in
maintaining the stability of iodinated Hb. Iodination was done in IODO-GEN-
coated iodination tubes from Pierce (Pierce Endogen, Rockford, Ill.) and fol-
lowed the suggested protocol. The assay used MultiScreen plates purchased from
Millipore (Bedford, Mass.). CDM solution was the suspension and washing
buffer, and 0.5% dry milk was used as the blocker.
The wild type and the hpuA strains to be tested were grown in iron-replete
and iron-stressed cultures and prepared as OD600  0.2 cell suspensions in CDM
solution. Hb was added to the final concentration of 0.1 M to 100 l of
gonococcal suspensions in the wells. The mixture was incubated at room tem-
perature for 30 min and filtered through the MultiScreen plate. After three
washes with CDM solution, labeled goat anti-human Hb antibody was added to
approximately 106 cpm per well. After another incubation of 30 min, the wells
were washed three times again, disks at the bottom of wells were punched out,
and radioactivity was counted in a gamma scintillation counter. Specific Hb
binding values were derived from the difference between the cpm bound in wells
with iron-stressed gonococci and those bound in wells with iron-replete gono-
FIG. 1. hpuA/B genotype of key strains constructed and/or used in
this study. The open arrow indicates that the gene is not expressed.
The solid arrow indicates that the gene is expressed.
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cocci. Specific counts accumulated from each test strain were then compared
with corresponding counts from the wild-type strain using paired Student’s t test.
RESULTS
In order to study the roles of HpuA and HpuB in the gono-
coccal Hb receptor, we constructed a hpuA hpuB mutant of
FA1090, FA7169, as illustrated in Fig. 1. Moving the hpuA
hpuB::cat DNA fragment from pUNCH280 into the Hb vari-
ant of FA1090 resulted in Cmr Hb FA7167. Transformation
of FA7167 with pUNCH272, which contained the wild-type
hpuB sequence, removed the cat cassette insert and resulted in
FA7169. The hpuB sequence of FA7169 was identical to that of
FA1090. The hpuB gene, along with its ribosome-binding site,
followed the hpuA promoter at a distance equal to that be-
tween hpuA and the promoter in FA1090, and HpuB was
expressed under iron-stressed growth conditions. FA7169
could not grow on Hb as a sole iron source but expressed
HpuB, as previously reported for the analogous hpuA nonpolar
insertion mutant FA6983 (8).
During the construction of FA7169, two mutants, FA7168
and FA7170, were discovered which were phenotypically Cms
but grew on Hb/Des plates (Hb). DNA sequencing revealed
that both mutants had the expected deletion of hpuA. FA7168
was hpuA hpuB::cat, while FA7170 was hpuA hpuB*650
(G217D), with a point mutation 650 bp downstream from the
beginning of the coding sequence. Both FA7168 and FA7170
grew on Hb/Des after insertional mutagenesis of hmbR (data
not shown), and thus HmbR was not responsible for the Hb
phenotype of either mutant. Insertional inactivation of tonB
resulted in an Hb phenotype in FA7170, but a tonB mutant of
FA7168 was still Hb (data not shown), indicating that they
used different mechanisms for Hb-supported growth. FA7168
was unable to grow on plates containing chloramphenicol (1
g/ml) and was highly sensitive to rifampin and Triton X-100,
while FA1090, FA7167, FA7169, and FA7170 were able to
grow on the same plates (data not shown).
After these initial characterizations, additional Hb mutants
were selected from hmbR mutants of FA7169, FA7185
(hmbR::cat) and FA7186 (hmbR::), on Hb/Des plates at fre-
quencies of about 106. DNA sequencing confirmed that there
were two classes of Hb revertants. One had single point
mutations in hpuB, and these were designated hpuA hpuB*
mutants. The other class did not have mutations in hpuB, but,
like FA7168, all were highly sensitive to Triton X-100 and
rifampin (data not shown). Mutants of this class were desig-
nated hpuA hgbX mutants, pending identification of the
gene(s) involved in the Hb phenotype. All 15 hpuB* mutants
contained a single predicted amino acid alteration, which were
clustered toward the C-terminal end of HpuB. Three muta-
tions were isolated independently multiple times (Fig. 2).
The Hb hpuA hpuB FA7169 and the Hb hpuA hpuB*
mutants expressed HpuB under iron-stressed conditions (Fig.
3). Insertional inactivation of the altered HpuB in FA7186H2
and FA7186H17 resulted in Hb transformants FA7246 and
FA7247 (data not shown). Thus, expression of HpuB was re-
quired for the utilization of Hb for growth. Further proof that
the point mutations in hpuB caused the Hb phenotype was
obtained by transforming FA7169 with PCR-amplified hpuB
DNA from FA7170 or FA7185H14. The hpuB gene was se-
quenced from two Hb transformants of each transformation
and confirmed that each carried the same hpuB point mutation
as the donor (data not shown).
Zones of growth around Hb were smaller for hpuA hpuB*
mutants than FA1090 Hb (Fig. 4), suggesting that the hpuB*
mutants required a higher Hb concentration for growth than
the wild type. Free heme also could be used by the hpuB*
FIG. 2. Illustration of point mutation sites found in FA7170 and
hpuA hpuB* mutants derived from FA7185 and FA7186. The arrows
indicate alterations of amino acids (aa), with amino acids of the wild
type on the top row and those of the mutants on the bottom row. The
# indicates sites with multiple occurrences. The corresponding sites of
mutation in hpuB are bp 650, 770, 1526, 1780, 1838, 2146, 2199, 2181,
2344, 2369, and 2378 from the beginning of coding sequence. The
shaded area is the signal sequence, and the boxes are seven regions of
homology derived by Lewis et al. (16) from their peptide alignment of
meningococcal HpuB- and TonB-dependent outer membrane proteins
described by Cornelissen et al. (9).
FIG. 3. Western blot analysis of whole-cell lysates prepared from
the indicated strains grown under iron-stressed condition. FA7185H1
and FA7185H2 were Hb revertants of FA7185. FA7186H1 and
FA7186H2 were revertants of FA7186. FA7186 H1 was an hgbX mu-
tant, while the other three were hpuB* mutants. The top panel was
probed with rabbit antiserum raised against the HpuB N-terminal
peptide, and the bottom panel was probed with rabbit antiserum raised
against the HpuA C-terminal peptide. The positions of size standards
are shown on the left (in kilodaltons).
FIG. 4. Plate assays testing the ability of indicated hpuA mutants
for growth on Hb and heme (Hm). Wells were cut into GCB/Des agar
and loaded with Hb (60 l at 10 g/l) and heme (60 l at 0.1 g/l).
All tested strains grew on heme. The hpuA hpuB strain FA7169
could not grow on Hb, but the hpuA hpuB* mutants could.
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mutants as an iron source, as previously described for FA1090
Hb (26). Both Hb FA1090 and Hb FA7169 showed similar
heme growth phenotypes, with an inner zone of inhibition and
an outer zone of growth around the well (Fig. 4). The zone of
inhibition reflects the sensitivity of these strains to heme; they
only grew on a narrow range of heme concentrations.
Growth of hpuA hpuB* mutants in liquid culture contain-
ing 1 M Hb and 100 M Desferal was inhibited by HSA,
while that of FA1090 Hb was not inhibited by HSA (Fig. 5).
Thus, growth of these mutants apparently relied on free heme
released extracellularly from Hb. The role of HpuA was fur-
ther investigated by constructing hpuA derivatives of the
hpuB* strains FA7170 and FA7185H14 (FA7242 and FA7243,
respectively). Growth of the hpuA hpuB* strains on Hb was
not inhibited by HSA (Fig. 5), confirming the importance of
HpuA in allowing the use of heme from Hb.
Insertional inactivation of hemA in the hpuB* mutants
FA7170 and FA7185H14 resulted in FA7244 and FA7245,
respectively, while the hemA mutant of FA7169 was designated
FA7288. All of these hemA mutants needed 	-aminolevulinic
acid to grow on GCB plates, but were able to grow on heme/
Des (data not shown). Both FA7244 and FA7245 were able to
grow on Hg/Des plates, but FA7288 did not grow on the same
plate (data not shown). These results demonstrated that Hb
was used as a heme source by the hpuA hpuB* mutants, while
hpuA hpuB FA7169 could not use Hb as a heme source.
The uptake of free heme by hpuB* mutants was studied by
measuring heme-dependent growth in liquid cultures. At heme
concentrations of 1 and 5 M, growth of all hpuB* and hpuB
strains was indistinguishable and quickly reached a plateau. At
heme concentrations of 0.05 to 0.1 M, all strains grew poorly
(data not shown). At 0.5 M heme, strains expressing HpuB
grew better than the HpuB FA7167. The hpuB* mutants
FA7170 and FA7186H16 grew slightly but reproducibly better
than their hpuB parents, FA7169 and FA7186 (Fig. 6 and
data not shown). Thus, at limiting heme concentrations, hpuB*
mutants apparently transported more free heme than their
hpuB parents.
In order to evaluate the relative roles of HpuA and HpuB in
Hb binding, qualitative and semiquantitative Hb binding assays
were carried out. Probing whole-cell dot blots with biotinylated
Hb showed that iron-stressed hpuA hpuB* mutants bound
Hb, although apparently less than FA1090 Hb. The binding
corresponded to the expression of HpuB, as detected by anti-
HpuB antibodies (data not shown). Radioimmunoassays fur-
ther confirmed that Hb bound to all mutants that expressed
HpuB regardless of their growth phenotype. FA7169, which
was Hb, made HpuB and bound Hb, whereas FA7168, which
FIG. 5. Growth of hpuA hpuB* mutants and hpuA hpuB* mu-
tants in medium supplemented with 1 M Hb (A) and 1 M Hb plus
HSA at 16 M (B). FA1090 Hb is the wild-type parent (F). FA6929
is an hpuA hpuB* mutant (E). The hpuA hpuB* strains FA7242 ()
and FA7243 (‚) were derivatives of the hpuA hpuB* mutants
FA7170 (f) and FA7185H14 (Œ), respectively.
FIG. 6. Growth of the hpuA hpuB* mutant and its hpuA hpuB
parent in medium supplemented with 0.5 M heme. FA1090 Hb is
the wild-type parent (F). FA7167 is the hpuA hpuB::cat negative
control (E). FA7169 (f) is the hpuB parent of FA7170 (). Results
presented in this graph were also true for FA7186H16 and its parent
FA7186. Similar results were observed in two other experiments.
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was Hb but could not express HpuB, did not bind Hb (data
not shown). Hb binding to each hpuA mutant, hpuB or
hpuB*, was significantly less than that of the wild type (P 

0.01, paired Student’s t test). With the exception of
FA7185H14, all hpuA mutants bound less than 30% of the
Hb bound to the wild type. Hb binding generally was not
increased by the hpuB* mutations; FA7185H14 was the only
strain that bound significantly more Hb than its hpuB parent
(Fig. 7).
DISCUSSION
N. gonorrhoeae ordinarily requires both HpuA and HpuB to
use human Hb as the source of iron for growth. Expression of
both proteins is controlled at the translational level by the
length of a run of guanine residues within sequence encoding
the mature HpuA protein (8). As expected, a mutant with an
in-frame deletion of hpuA that expressed wild-type HpuB was
unable to grow on Hb. However, we were able to identify Hb
revertants from the hpuA mutant at frequencies of about
106. Two classes of revertants were identified: hpuB* mu-
tants, which had single point mutations in hpuB, and hgbX
mutants, which had mutations in a still unidentified locus or
loci. Involvement of HmbR, the single-component, TonB-de-
pendent outer membrane receptor known to bind and acquire
iron from Hb in meningococci (22), was ruled out after inser-
tional mutagenesis of hmbR.
The neisserial transferrin and lactoferrin receptors are sim-
ilar to the HpuAB Hb receptor. All are bipartite, TonB-de-
pendent outer membrane receptors, consisting of a lipoprotein
and an integral outer membrane protein. The lipoproteins
TbpB and LbpB are necessary for full binding of ligand, but are
not absolutely required for iron acquisition (2, 4, 10, 19). In
contrast, both HpuA and HpuB are required for iron acquisi-
tion from Hb in N. gonorrhoeae (8) and Neisseria meningitidis
(18). However, the current work proves that the requirement
for HpuA can be bypassed under certain circumstances by
point mutations in HpuB.
Growth on Hb by hpuA hpuB* mutants was TonB and
HpuB dependent, indicating that iron acquisition was an en-
ergy-dependent process involving HpuB. All hpuA mutants
bound less Hb than the wild type, confirming the importance of
HpuA in the ligand binding. The point mutations in HpuB that
restored growth on Hb in the absence of HpuA did not signif-
icantly increase Hb binding, with the exception of FA7185H14.
None of the mutations in HpuB restored full Hb binding to the
cell surface, and therefore growth apparently was not due
merely to increased ligand binding. The low Hb binding effi-
ciency of hpuA hpuB* mutants might have contributed to the
higher Hb concentration required for growth on Hb.
HSA inhibited Hb-dependent growth of hpuB* mutants,
suggesting that free heme was released external to the outer
membrane before it was internalized, presumably by passing
through a pore in the integral outer membrane protein HpuB.
Proof that heme released from Hb entered intact was provided
by demonstration of Hb-dependent growth in hpuA hpuB*
hemA:: mutants. In these mutants, heme released from Hb
was used both as a porphyrin source and as an iron source. The
mechanism of heme removal from Hb is currently unknown.
Growth of hpuA hpuB* mutants on Hb was inhibited by
HSA, but HSA was not growth inhibitory in hpuB* strains that
expressed HpuA. These results suggested that HpuA both in-
creased Hb binding and allowed use of heme released exter-
nally from Hb. The current results are insufficient to determine
precise roles of HpuA or HpuB in ligand binding. HpuA might
increase Hb binding by stabilizing a conformation of HpuB
that has high affinity for Hb. Apparent protection of heme
from HSA binding by HpuA could have been due to steric
effects of the Hb receptor, but also could have been due to
increased release of heme from HSA.
In liquid cultures with limiting heme concentrations, hpuA
hpuB* mutants grew slightly better than their hpuA hpuB
parents did. Thus, the point mutations in HpuB might have
altered the transmembrane barrel and increased the ability of
free heme to traverse the membrane. However, we were un-
able to determine the relative contribution of heme binding
and heme entry to the heme-dependent growth of hpuA
hpuB* mutants. With regard to Hb-dependent growth, our
data did not show a general increase of Hb binding in the
hpuB* mutants in comparison to their hpuB parents. The
hpuB* mutations could have effected either increased heme
release from Hb or increased transport of heme through HpuB
or both.
The mutations in HpuB occurred in clusters, particularly
near the C terminus, but the meaning of this distribution is not
yet clear. None of the mutations was likely to be in the putative
N-terminal plug that is characteristic of TonB-dependent sid-
erophore receptors (5). Until a crystal structure is determined
for HpuB, the exact location of point mutations in the barrel or
outer loops of HpuB will remain conjectural. The point muta-
tions in HpuB that restored function of the receptor in the
absence of the otherwise requisite partner HpuA should prove
helpful in ultimately understanding the structure-function re-
lationship in HpuAB. Likewise, the other class of mutations,
FIG. 7. Results from radioimmunoassays of Hb binding of hpuA
mutants. FA7169, FA7185, and FA7186H1 are HpuB, while the rest
are HpuB*. Hb binding to each mutant was significantly less than that
of the wild type (P 
 0.01, paired Student’s t test). # indicates that
FA7185H14 bound more Hb than its parent FA7185 (P 
 0.01, Stu-
dent’s t test). The other FA7185 derivatives and FA7170 did not bind
significantly more Hb than their HpuB parents. Since experiments
were done over a period of 4 weeks using different batches of iodinated
anti-human Hb antibody, binding data for each tested strain are pre-
sented as a percentage of that of the corresponding wild-type control
(FA1090 Hb). Bars indicate standard deviations. The number at the
base of each column represents the number of determinations.
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designated hgbX, should prove useful in understanding Hb
receptor-independent and TonB-independent mechanisms for
heme utilization, and these studies are being actively pursued.
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